Skip to main content
. 2014 Feb 3;111(7):2656–2661. doi: 10.1073/pnas.1323436111

Table 1.

Peptides used in these studies

MHCII Protein Peptide Sequence* Groove position (p) 123456789 Form (soluble or MHCII-linked)
I-Ag7 Insulin (B:9–23) Natural SHLVEALYLVCGERG Soluble
I-Ag7 Insulin (B:9–23) R1:RE    HLREALYLVCEERG Linked
I-Ag7 Insulin (B:9–23) R2:RE   HLVRALYLVCGERG Linked
I-Ag7 Insulin (B:9–23) R3:RE HLVERLYLVCGEEG Both
I-Ag7 Insulin (B:9–23) R3:REss HLVERLYLVCGEEG-α62 Linked
I-Ag7 Insulin (B:9–23) R3:RGE HLVERLYLVCGGEG Soluble
I-Ag7 Insulin (B:9–23) R3:RGEss HLVERLYLVCGGEG-α62 Linked
I-Ag7 Insulin (B:9–23) R3:E HLVEALYLVCGEEG Soluble
I-Ag7 Insulin (B:9–23) R3:RAE    VERLYLVAGEEG Linked
I-Ag7 Lysozyme HEL    MKRHGLDNYRGY Linked
I-Ag7 Chromogranin A HRPI    HRPIWARMD Soluble
I-Ag7 Chromogranin A ChgA     SRLGLWSRMD Linked
I-Ab MHCII Eα 3K ASFEAQKAKANKAVDKA Linked
na Tetnus toxin TT QYIKANSKFIGITE Soluble

na, not applicable.

*

Boldcase indicates differences from the wild type peptide.

Disulfide linked to I-Ag7 (p6Cys to I-Ag7-α62Asn mutated to Cys).

Peptide that mimics the Chromogranin A WE-14 peptide.

Peptide from mouse MHCII Eα mutated at three positions to lysine.